Skip to main content
GE HealthCare Technologies Inc. (BMV:GEHC)
Mexico flag Mexico · Delayed Price · Currency is MXN
1,364.00
-30.00 (-2.15%)
At close: May 2, 2025, 2:00 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Product
13.08B
Log In
Log In
Log In
Log In
Product Growth
-0.40%
Log In
Log In
Log In
Log In
Service
6.60B
Log In
Log In
Log In
Log In
Service Growth
2.68%
Log In
Log In
Log In
Log In
Imaging Revenue (Post-Q2 2024)
8.86B
Log In
Log In
Log In
Log In
Imaging Revenue (Post-Q2 2024) Growth
-
Log In
Log In
Log In
Log In
Advanced Visualization Solutions (AVS)
5.13B
Log In
Log In
Log In
Log In
Advanced Visualization Solutions (AVS) Growth
-
Log In
Log In
Log In
Log In
Patient Care Solutions (PCS)
3.13B
Log In
Log In
Log In
Log In
Patient Care Solutions (PCS) Growth
-0.54%
Log In
Log In
Log In
Log In
Pharmaceutical Diagnostics (PDx)
2.51B
Log In
Log In
Log In
Log In
Pharmaceutical Diagnostics (PDx) Growth
8.76%
Log In
Log In
Log In
Log In
Other
52.00M
Log In
Log In
Log In
Log In
Other Growth
-21.21%
Log In
Log In
Log In
Log In
Imaging
-
Log In
Log In
Log In
Log In
Imaging Growth
-
Log In
Log In
Log In
Log In
Ultrasound
-
Log In
Log In
Log In
Log In
Ultrasound Growth
-
Log In
Log In
Log In
Log In

EBIT by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Imaging EBIT (Post-Q2 2024)
962.00M
Log In
Log In
Log In
Log In
Imaging EBIT (Post-Q2 2024) Growth
-
Log In
Log In
Log In
Log In
Advanced Visualization Solutions (AVS) EBIT
1.12B
Log In
Log In
Log In
Log In
Advanced Visualization Solutions (AVS) EBIT Growth
-
Log In
Log In
Log In
Log In
Patient Care Solutions (PCS) Segment EBIT
347.00M
Log In
Log In
Log In
Log In
Patient Care Solutions (PCS) Segment EBIT Growth
-9.40%
Log In
Log In
Log In
Log In
Pharmaceutical Diagnostics (PDx) Segment EBIT
783.00M
Log In
Log In
Log In
Log In
Pharmaceutical Diagnostics (PDx) Segment EBIT Growth
26.90%
Log In
Log In
Log In
Log In
Other Segment EBIT
2.00M
Log In
Log In
Log In
Log In
Other Segment EBIT Growth
-81.82%
Log In
Log In
Log In
Log In
Imaging Segment EBIT
-
Log In
Log In
Log In
Log In
Imaging Segment EBIT Growth
-
Log In
Log In
Log In
Log In
Ultrasound Segment EBIT
-
Log In
Log In
Log In
Log In
Ultrasound Segment EBIT Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
USCAN
8.98B
Log In
Log In
Log In
Log In
USCAN Growth
5.03%
Log In
Log In
Log In
Log In
EMEA
5.05B
Log In
Log In
Log In
Log In
EMEA Growth
-0.14%
Log In
Log In
Log In
Log In
China
2.36B
Log In
Log In
Log In
Log In
China Growth
-15.26%
Log In
Log In
Log In
Log In
Rest of World
3.28B
Log In
Log In
Log In
Log In
Rest of World Growth
3.86%
Log In
Log In
Log In
Log In

Other

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Products Remaining Performance Obligations (RPO)
4.76B
Log In
Log In
Log In
Log In
Products Remaining Performance Obligations (RPO) Growth
-3.55%
Log In
Log In
Log In
Log In
Services Remaining Performance Obligations (RPO)
9.74B
Log In
Log In
Log In
Log In
Services Remaining Performance Obligations (RPO) Growth
0.12%
Log In
Log In
Log In
Log In
Total Remaining Performance Obligations (RPO)
14.49B
Log In
Log In
Log In
Log In
Total Remaining Performance Obligations (RPO) Growth
-1.12%
Log In
Log In
Log In
Log In